Brief: Orchard Therapeutics Announces Positive Clinical And Preclinical Data In Programs Targeting Neurometabolic And Cns Disorders At Asgct
19/05/2023 14:44
Orchard Therapeutics PLC OT10y.F :
* ORCHARD THERAPEUTICS ANNOUNCES POSITIVE CLINICAL AND
PRECLINICAL
DATA IN PROGRAMS TARGETING NEUROMETABOLIC AND CNS DISORDERS AT
ASGCT
Source text for Eikon: ID:nGNX9V5tlQ
Further company coverage: OT10y.F
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln